Burzynski Research Institute Inc BZYR:OTCPK

RT Quote | Exchange | USD
Last | 03/05/21 EST
0.049quote price arrow down-0.003 (-5.7692%)
Volume
14,385
52 week range
0.01 - 0.10

...

Loading . . .

KEY STATS

  • Open0.031
  • Day High0.049
  • Day Low0.031
  • Prev Close0.052
  • 52 Week High0.10
  • 52 Week High Date08/28/20
  • 52 Week Low0.01
  • 52 Week Low Date06/03/20
  • Market Cap6.44M
  • Shares Out131.45M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.86
  • 1 Year % Change345.45

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-4.83
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-1.336M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Burzynski Research Institute Inc News

There is no recent news for this security.

Latest BZYR News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Burzynski Research Institute, Inc. is engaged in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids, which are known under the trade name Antineoplastons. Antineoplastons are found in the bodily fluids of humans and food. The Company is reviewing data of its Phase II clinical trials of Antineoplastons relating to the treatment of various cancers. All...
Stanislaw Burzynski M.D., Ph.D.
Chairman
Tomasz Janicki M.D.
Vice President
Address
12000 Richmond Ave
Houston, TX
77082
United States